Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants

To explore the non‐pharmacological correlates of the perceived effectiveness of antidepressants (ADs), thereby enhancing understanding of the mechanisms involved in recovery from depression while taking ADs.

[1]  D. Klein,et al.  Are there differences between women's and men's antidepressant responses? , 2002, The American journal of psychiatry.

[2]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[3]  M. Beneke,et al.  Placebo response in antidepressant drug trials , 1994, European Psychiatry.

[4]  E. A. Whitham,et al.  Antidepressants from a public health perspective: re‐examining effectiveness, suicide, and carcinogenicity , 2013, Acta psychiatrica Scandinavica.

[5]  C. Dowrick,et al.  Estimating probability of sustained recovery from mild to moderate depression in primary care: evidence from the THREAD study , 2010, Psychological Medicine.

[6]  J. Read,et al.  A literature review and meta‐analysis of drug company–funded mental health websites , 2013, Acta psychiatrica Scandinavica.

[7]  Assen Alladin.  The Power of Belief and Expectancy in Understanding and Management of Depression , 2013, The American journal of clinical hypnosis.

[8]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[9]  J. Read,et al.  Patient-Centered Perspectives on Antidepressant Use , 2014 .

[10]  W. Brown,et al.  Are placebo controls necessary to test new antidepressants and anxiolytics? , 2002, The international journal of neuropsychopharmacology.

[11]  I. Kirsch,et al.  A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression , 2012, PloS one.

[12]  Michael J. Constantino,et al.  The relationship between the therapeutic alliance and treatment outcome in two distinct psychotherapies for chronic depression. , 2013, Journal of consulting and clinical psychology.

[13]  J. Moncrieff,et al.  Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. , 2012, The British journal of psychiatry : the journal of mental science.

[14]  A. Kiss,et al.  Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. , 2010, The Journal of clinical psychiatry.

[15]  W. Brown,et al.  The persistence of the placebo response in antidepressant clinical trials. , 2008, Journal of psychiatric research.

[16]  M. Linden,et al.  What do psychiatrists talk about with their depressed patients parallel to prescribing an antidepressant? , 2011, International journal of psychiatry in clinical practice.

[17]  M. Olfson,et al.  National patterns in antidepressant medication treatment. , 2009, Archives of general psychiatry.

[18]  Fabrizio Benedetti,et al.  Placebo and the new physiology of the doctor-patient relationship. , 2013, Physiological reviews.

[19]  L. Markson,et al.  Discontinuation of use and switching of antidepressants: influence of patient-physician communication. , 2002, JAMA.

[20]  C. Dowrick,et al.  Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit , 2013, BMJ.

[21]  C. Bassetti,et al.  Chronic Insomnia: Clinical and Research Challenges – An Agenda , 2010, Pharmacopsychiatry.

[22]  C. Dowrick,et al.  Exploratory Review of Placebo Characteristics Reported in Randomised Placebo Controlled Antidepressant Drug Trials , 2011, Pharmacopsychiatry.

[23]  J. Read,et al.  Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants , 2014, Psychiatry Research.

[24]  L. Venturato,et al.  Mediating roles of adherence attitude and patient education on antidepressant use in patients with depression. , 2011, Perspectives in psychiatric care.

[25]  J. Read,et al.  The pharmaceutical industry and the internet: Are drug company funded depression websites biased? , 2009 .

[26]  R. Epstein,et al.  Types of information physicians provide when prescribing antidepressants , 2006, Journal of General Internal Medicine.

[27]  C. Reynolds,et al.  Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults , 2009, Social Psychiatry and Psychiatric Epidemiology.

[28]  J. Read,et al.  What prevents GPs from using outside resources for women experiencing depression? A New Zealand study. , 2001, Family practice.